Cov lus qhia
| Kev tshwm sim | Lub teeb daj hmoov |
| Kev coj dawb huv | 98.0% min |
| So | Soluble hauv methanol |
| Daim qhia npe | UV Spectrum los ntawm HPLC - Txiv ¹h nmr spectroscopy |
Cov Ntawv Thov
Harringtonin yog lub ntuj alkaloid feem ntau kawm thiab thov teb ntawm oncology thiab kev tshawb nrhiav pharmacological. Nws yog muab tau los ntawm qee cov nroj tsuag cog thiab tau raug tshawb nrhiav rau nws cov peev txheej antectumor, tshwj xeeb tshaj tawm tsam cov lus mob ntshav thiab lwm yam hematological malignancies. Qhov sib xyaw ua haujlwm los ntawm kev txwv tsis pub muaj protein synhin synthesis ntawm kev sib tw qib, yog li kev mob siab rau lub hlwb. Hauv kev tshawb nrhiav cov chaw kuaj mob thiab cov kev tshawb fawb ua ntej, Harringtonin thiab nws cov kev kho mob derivatives tau raug ntsuas rau kev siv hauv kev kho mob los txhim kho cov neeg sawv cev anticancer uas twb muaj lawm. Beyond cancer treatment, it has also attracted research interest in virology and immunology, where its mechanism of protein synthesis inhibition provides a basis for studying viral replication and immune response modulation. Ib qho ntxiv, Harringtonin yog qhov tseem ceeb siv hauv kev tshuaj pom kev, kev ua qauv coj ua semi- Cov analogs nrog kev txhim kho lub chaw muag tshuaj profiles.
Cov txiaj ntsig
Cov txiaj ntsig ntawm Harringtonin tshwm sim los ntawm nws cov kev ua haujlwm muaj zog, tshwj xeeb mechanism ntawm kev nqis tes ua, thiab cov peev txheej ntawm kev kho kev txhim kho tshiab. Nws lub peev xwm los xaiv cov protein synibsis nyob rau malignant cov xov xwm nws ua ib qho kev pab cuam anticancer anticancer - tiv taus cancers. Raws li lub ntuj sib xyaw, nws muab cov kws tshawb nrhiav nrog lub moj khaum nyuaj uas tuaj yeem ua tau zoo ntxiv rau hauv cov derivatives tau zoo dua. Nws qhov kev daws teeb meem ntawm oncology thiab BOIN BOINLENS Nws cov tau, ua rau nws muaj txiaj ntsig tsis yog rau kev tshawb fawb txog kev mob kheesxaws. Tsis tas li ntawd, nws lub luag haujlwm raws li kev siv molecule hauv kev siv tshuaj kho yeeb yam, txhawb tus qauv tshiab ntawm kev kho mob tshiab nrog cov teebmeem kev cuam tshuam. Qhov kev sib xyaw ua ke ntawm potency thiab versatility ua harringtonin ib qho cuab yeej tseem ceeb rau kev kho mob thiab kev tshawb fawb cov ntawv thov.
Tag
Harringtonin (CASE 26833-85-2) Yog cov ntawv thov tseem ceeb hauv kev tshawb fawb cancer, chaw muag tshuaj, thiab kev txhim kho tshuaj. Nws cov protein synthesis kev cog lus, thaum nws cov nqi hluav taws xob tsis txaus siab ua rau kev tshawb fawb ua kom muaj kev tsim kho tshiab hauv kev tshawb xyuas kev ua haujlwm hauv kev ua yeeb yam thiab kev tshawb xyuas tshuaj yeeb. Muaj cov txiaj ntsig suav nrog kev ua tau zoo biological, thiab kev yoog raws kev txhim kho, Harringtonin tseem ua haujlwm hauv kev txhim kho kev kho mob niaj hnub thiab kev tshawb fawb.
Cim npe nrov: Harringtonin 丨 CAST 26833-85-2, Tuam Tshoj Harringtonin att Cas 26833-85-2 manufacturers, chaw tsim khoom

